在合并症负担高的产科人群中复发性严重孕产妇发病率
本研究为回顾性队列研究,纳入2015至2018年美国东南部单中心852例至少两次分娩且孕周≥23周的患者,评估既往严重孕产妇发病率(SMM)者后续妊娠再发SMM的风险。既往输血SMM者后续妊娠输血SMM风险为57.8% vs 3.5%(RR 16.3,95%CI 10.8-24.6),既往非输血SMM者后续非输血SMM风险为16.7% vs 0.7%(RR 23.2,95%CI 6.3-85.4)。
要点
- 既往输血SMM者后续妊娠输血SMM风险显著升高(57.8% vs 3.5%,RR 16.3)。
- 既往非输血SMM者后续非输血SMM风险显著升高(16.7% vs 0.7%,RR 23.2)。
- 既往输血SMM者后续非输血SMM风险亦升高(RR 6.2,95%CI 1.7-22.6)。
核心结论
- 既往SMM者后续妊娠再发SMM风险极高,高于既往估计。
- 未来研究应评估合并症及包括社会脆弱性在内的其他结构决定因素的贡献,以帮助设计降低后续妊娠风险的干预措施。
研究设计与样本
- 回顾性队列研究,纳入2015至2018年美国东南部单中心852例至少两次分娩且孕周≥23周的患者。
- 主要暴露为既往妊娠基于CDC定义并使用ICD-9或ICD-10编码的输血SMM。
- 主要结局为研究期间任何后续妊娠的输血SMM,采用广义估计方程模型估计相对风险(RR)及95%CI。
主要发现
- 首次捕获妊娠中输血SMM和非输血SMM分别发生90例(10.6%)和18例(2.1%),后续妊娠分别发生79例(9.3%)和9例(1.1%)。
- 首次捕获妊娠和后续妊娠中最常见的合并症分别为贫血(34.6-40.0%)、肥胖(33.4-40.4%)、物质使用障碍(14.2-14.6%)和子痫前期(12.0-11.4%)。
- 首次捕获妊娠有输血SMM者后续妊娠输血SMM风险为57.8% vs 3.5%(RR 16.3,95%CI 10.8-24.6)。
- 首次捕获妊娠有非输血SMM者后续妊娠非输血SMM风险为16.7% vs 0.7%(RR 23.2,95%CI 6.3-85.4)。
- 首次捕获妊娠有输血SMM者后续妊娠发生非输血SMM风险升高(RR 6.2,95%CI 1.7-22.6);首次捕获妊娠有非输血SMM者后续妊娠输血SMM风险无统计学显著性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the risk of severe maternal morbidity (SMM) in subsequent pregnancies in patients who experienced SMM in a previous pregnancy compared with those who did not. METHODS: We conducted a retrospective cohort study of patients with two or more deliveries at 23 or more weeks of gestation at a single Southeastern U.S. tertiary care center between 2015 and 2018. The primary exposure was SMM including transfusion (transfusion SMM) in a previous pregnancy, as defined by the Centers for Disease Control and Prevention, using International Classification of Diseases, Ninth or Tenth Revision codes. The primary outcome was transfusion SMM in any subsequent pregnancy in the study time frame. Generalized estimating equation models were used to estimate the relative risk (RR) and associated 95% CIs of transfusion SMM in patients with transfusion SMM in a prior pregnancy compared with patients without transfusion SMM in a previous pregnancy. Severe maternal morbidity without transfusion (nontransfusion SMM) and cross-analysis to determine risk of a different type of SMM after a history of SMM were analyzed similarly. RESULTS: Of 852 included patients, transfusion SMM and nontransfusion SMM occurred in 90 (10.6%) and 18 (2.1%), respectively, in the first captured pregnancy and in 79 (9.3%) and 9 (1.1%), respectively, in subsequent pregnancies. Anemia (34.6-40.0%), obesity (33.4-40.4%), substance use disorder (14.2-14.6%), and preeclampsia (12.0-11.4%) were the most prevalent morbidities at first captured and subsequent pregnancies, respectively. There was a 16-fold higher risk of transfusion SMM in a subsequent pregnancy after experiencing transfusion SMM in the first captured pregnancy (57.8% vs 3.5%, RR 16.3 95% CI, 10.8-24.6). Nontransfusion SMM was similarly higher in patients with nontransfusion SMM in their first captured pregnancy compared with those without (16.7% vs 0.7%, RR 23.2 95% CI, 6.3-85.4). Additionally, patients who experienced transfusion SMM in their first captured pregnancies were at sixfold higher risk of developing nontransfusion SMM in a subsequent pregnancy (RR 6.2, 95% CI, 1.7-22.6). However, in cross-analysis of patients who experienced nontransfusion SMM, the risk of transfusion SMM in a subsequent pregnancy was not statistically significant. CONCLUSION: The risks of SMM in subsequent pregnancies after previous SMM are extremely high and are higher than previous estimates. Future studies should estimate the contributions of comorbidities and other structural determinants including social vulnerability to help design interventions to reduce subsequent pregnancy risks.
引用
- McIlwraith C, Sanusi A, McGwin G, et al. Recurrent Severe Maternal Morbidity in an Obstetric Population With a High Comorbidity Burden. Obstet Gynecol. 2023. PMID: 37989147. doi:10.1097/AOG.0000000000005453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。